Results 171 to 180 of about 17,515,407 (332)
Harnessing polyploidy for climate-resilient crops: Lessons from the evolutionary model, allotetraploid cotton. [PDF]
Wang M +4 more
europepmc +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Administrative Restructuring Versus Product Safety: The Case for Subsequent Importer Scheme (SIS) in Importer Constitutional Changes. [PDF]
Sankhyayan AS.
europepmc +1 more source
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source
Can digital M&As promote green innovation? Evidence from manufacturing companies in China. [PDF]
Wang X, Huang W.
europepmc +1 more source
Accommodating Public Interest Considerations in Domestic Merger Control: Empirical Insights
David Reader
semanticscholar +1 more source
Astrocyte heterogeneity in brain metastases
Astrocytes emerge as pivotal regulators of metastatic colonization, survival, immune remodeling, and therapy response associated with an increasing heterogeneity that requires spatially and longitudinally resolved approaches to uncover regulatory programs and guide context‐specific therapies.
Carolina Hernández‐Oliver +2 more
wiley +1 more source
Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe. [PDF]
Fabian D, Wild C.
europepmc +1 more source
Merger control and the rule of law
Abdullah Khan, R.A., Davies, G.T.
openaire +2 more sources

